Rabbit anaesthesia: alfaxalone-based protocols vs ketamine–medetomidine combinations — induction quality, cardiorespiratory depression and recovery — POSSIBLE

In rabbits, how do alfaxalone-based protocols compare with ketamine–medetomidine (and other ketamine) combinations for induction quality, cardiorespiratory depression and recovery?

Shelf #327 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE: The drafted head-to-head — alfaxalone vs ketamine–medetomidine from the Grint programme — does not exist as a single cardable record: Grint 2008's alfaxalone evaluation (PMID: 18820329) carries no abstract and no comparator in its PubMed record, so it cannot be carded, and Grint's randomised blinded ketamine trial compares ketamine–medetomidine against ketamine–midazolam, not against alfaxalone. The one direct alfaxalone-vs-ketamine comparison found at the gate is a sedation (not surgical anaesthesia) crossover: Knutson 2022 (9 New Zealand White rabbits, randomised, blinded scorer) found alfaxalone–butorphanol–midazolam and ketamine–butorphanol–midazolam produced identical median total sedation scores (10 vs 10), successful sham radiographs in all rabbits, and no significant difference in physiologic parameters — with significantly longer recumbency on the alfaxalone protocol. On the ketamine side, Grint 2008 (50 rabbits, randomised prospective blinded clinical trial) shows ketamine–medetomidine acts faster than ketamine–midazolam (loss of righting reflex 1.64 vs 2.28 minutes) with significantly lower heart rate, SpO2 and isoflurane requirement, and laryngospasm in 3 rabbits. On the alfaxalone side, Navarrete-Calvo 2014 shows alfaxalone induction after medetomidine–morphine premedication in 10 rabbits caused postinduction apnoea of 20-27 minutes requiring intermittent positive pressure ventilation, with cardiorespiratory variables remaining depressed throughout — the deepest depression signal in the pack, in combination rather than from alfaxalone alone; Huynh 2015 (10 rabbits, three-way crossover) shows i.m. alfaxalone alone gives dose-dependent immobilisation (36.9-58.4 minutes) with nociceptive reflexes preserved at every dose. Drafted Nov 10, 2026 (VetMed build, topic #327); all figures from abstracts fetched and verified at drafting.

Knutson 2022: alfaxalone–butorphanol–midazolam vs ketamine–butorphanol–midazolam in 9 rabbits — median sedation score 10 vs 10 and no significant physiologic difference, but recumbency significantly longer with alfaxalone

Complete crossover study (record's own wording); publication type: Randomized Controlled Trial, Veterinary; serial parameters and sedation scores collected by an investigator blind to treatment group

Who: Rabbits (Companion Exotics / laboratory): healthy New Zealand White rabbits (n = 9; age, 6 mo) in a complete crossover study, randomly receiving intramuscular midazolam (1 mg/kg IM) and butorphanol (1 mg/kg IM) combined with either alfaxalone (2 mg/kg IM; ABM) or ketamine (5 mg/kg IM; KBM). Time to first effects, recumbency, and standing (recovery) were recorded; every 5 min during recumbency an investigator blind to treatment group collected serial physiologic parameters and sedation scores. At 5 min after rabbits became recumbent, manipulations mimicking 2-view radiography were performed and a cephalic intravenous catheter placed; at 30 min after drug injection, flumazenil (0.05 mg/kg IM) was administered for reversal. Food consumption and fecal output were measured for 3 d after each study day.

Result: Time to standing and duration of recumbency differed significantly between groups. The median (range) of the total sedation score for ABM was 10 (8 to 10) and for KBM was 10 (6 to 10). Sham radiographs were successful in all rabbits in both groups. Physiologic parameters were not significantly different between groups over time. At 24 h after drug treatment, KBM-treated rabbits showed reduced food intake and both groups showed reduced fecal output. Total sedation scores decreased significantly over time in KBM rabbits (P < 0.001) but not in ABM rabbits (P = 1). The duration of recumbency was significantly longer in ABM rabbits than in KBM rabbits. Both protocols produced sufficient sedation for radiograph acquisition without clinically significant adverse effects.

Watch out: This is a sedation study for radiography in 9 healthy laboratory rabbits, not surgical anaesthesia, and the ketamine arm is paired with butorphanol–midazolam — not the medetomidine combination in the shelf question. Flumazenil reversal at 30 minutes shapes the recovery comparison, and the abstract reports no numeric times for the significantly longer ABM recumbency.

Knutson KA, Petritz OA, Thomson AE, Balko JA. Intramuscular Alfaxalone-Butorphanol-Midazolam Compared with Ketamine-Butorphanol-Midazolam in New Zealand White Rabbits. Journal of the American Association for Laboratory Animal Science. 2022;61(5):475-481. PMID: 36028310. Registry ID: none in the record. MeSH: Animals · Butorphanol/pharmacology · Cross-Over Studies · Flumazenil · Hypnotics and Sedatives · Injections, Intramuscular/veterinary · *Ketamine/pharmacology · Midazolam/pharmacology · *Pregnanediones/pharmacology · Rabbits

Grint 2008: ketamine–medetomidine vs ketamine–midazolam in 50 rabbits — faster induction (1.64 vs 2.28 min) and lower heart rate, SpO2 and isoflurane setting with medetomidine, plus laryngospasm in 3 rabbits

Randomized, prospective, blinded clinical trial (record's own wording); publication type: Randomized Controlled Trial; MeSH includes Double-Blind Method

Who: Rabbits (Companion Exotics): 50 rabbits (25 male, 25 female) of different breeds undergoing ovariohysterectomy or castration, 12.7 +/- 9.8 months old, body mass 2.24 +/- 0.61 kg. Ketamine (15 mg kg(-1)) and midazolam (3 mg kg(-1)) (KMZ) or medetomidine (0.25 mg kg(-1)) (KMT) were administered by intramuscular (IM) injection; 10 minutes later blind intubation of the trachea was attempted, with time taken, number of attempts and a subjective ease score recorded. Isoflurane (range 0-3.6%) in 100% oxygen maintained anaesthesia; carprofen and dextrose saline were given intravenously. Heart rate (HR), respiratory rate (RR) and SpO(2) were monitored during surgery; times to extubation and first head lift were recorded; group KMT received atipamezole (0.5 mg kg(-1)) IM 30 minutes after discontinuation of isoflurane.

Result: Mean time to loss of righting reflex (LRR) (+/- SD) was significantly shorter with KMT (1.64 +/- 0.55 minutes) compared with KMZ (2.28 +/- 0.66 minutes). Intubation was not possible in seven rabbits (three with KMT, four with KMZ) and three with KMT developed laryngospasm. Mean HR, SpO(2) and vaporizer settings were all significantly lower in group KMT. The authors concluded that KMT has a faster onset of action and a greater isoflurane-sparing effect when compared with KMZ, and that rabbits with KMT were more prone to laryngospasm and had significantly lower HR.

Watch out: The comparator is ketamine–midazolam, not an alfaxalone protocol — this card defines the ketamine–medetomidine side of the shelf (faster onset, more cardiorespiratory depression, laryngospasm risk) rather than answering alfaxalone vs ketamine–medetomidine directly. Atipamezole reversal given only to the KMT group confounds any recovery-time comparison between the groups.

Grint NJ, Murison PJ. A comparison of ketamine-midazolam and ketamine-medetomidine combinations for induction of anaesthesia in rabbits. Veterinary anaesthesia and analgesia. 2008;35(2):113-21. PMID: 18179655. Registry ID: none in the record. MeSH: Analgesics/administration & dosage · Anesthesia/*veterinary · Anesthesia Recovery Period · Anesthetics, Combined/*administration & dosage · Animals · Blood Gas Analysis/veterinary · Double-Blind Method · Female · Heart Rate/drug effects · Hypnotics and Sedatives/administration & dosage · Injections, Intramuscular/veterinary · Ketamine/administration & dosage · Male · Medetomidine/administration & dosage · Midazolam/administration & dosage · Oxygen/blood · Prospective Studies · Rabbits/*physiology/surgery · Respiration/drug effects · Treatment Outcome

Navarrete-Calvo 2014: alfaxalone induction after medetomidine–morphine premedication in 10 rabbits caused postinduction apnoea of 20-27 minutes and profound cardiorespiratory depression

Crossover experimental study (record's own wording); randomisation not stated in the record

Who: Rabbits (Companion Exotics / laboratory): 10 New Zealand White rabbits in a crossover experimental study: 200 microg/kg medetomidine and 1 (M1) or 2 mg/kg (M2) morphine were administered intramuscularly. After preoxygenation, anaesthesia was induced with alfaxalone at 10 mg/kg intravenously; the trachea was intubated and 60 per cent oxygen provided. Heart and respiratory rates (HR and RR), direct arterial pressures (APs), arterial pH (pHa), PaO2, PaCO2 and SaO2 were taken at baseline, after premedication and every 10 minutes during the 90 minutes following induction; times to return of ear pinch, toe pinch and righting reflexes were recorded.

Result: Compared to baseline values, HR, RR, APs, PaO2 and SaO2 decreased significantly after premedication in both groups. Postinduction apnoea of 20 +/- 10 with M1 and 27 +/- 18 minutes with M2 was experienced following alfaxalone administration; intermittent positive pressure ventilation was applied until spontaneous breathing efforts appeared. Cardiovascular variables, RR and pHa remained below, and PaCO2 over baseline values during the anaesthetic period. No significant differences were observed in the recovery times. The authors concluded that morphine at 1 or 2 mg/kg combined with medetomidine and alfaxalone in rabbits produced a suitable level of anaesthesia, although profound cardiorespiratory depression was found.

Watch out: There is no ketamine comparator and the only contrast is morphine dose: the profound depression and prolonged apnoea belong to the medetomidine-premedicated combination as a whole, not to alfaxalone alone, and the alfaxalone dose here (10 mg/kg i.v.) is an induction dose after heavy premedication. Ten laboratory rabbits; ventilation support was required by design of the protocol's monitoring.

Navarrete-Calvo R, Gomez-Villamandos RJ, Morgaz J, Manuel Dominguez J, Fernandez-Sarmiento A, Munoz-Rascon P, Lopez Villalba I, Del Mar Granados M. Cardiorespiratory, anaesthetic and recovery effects of morphine combined with medetomidine and alfaxalone in rabbits. The Veterinary record. 2014;174(4):95. PMID: 24408312. Registry ID: none in the record. MeSH: Anesthesia/*veterinary · Anesthesia Recovery Period · Anesthetics, Combined/*administration & dosage · Animals · Blood Gas Analysis/veterinary · Blood Pressure/drug effects · Cross-Over Studies · Female · Injections, Intramuscular/veterinary · Medetomidine/administration & dosage · Morphine/administration & dosage · Pregnanediones/administration & dosage · Rabbits/*physiology · Respiration/drug effects · Respiratory Rate/drug effects/physiology

Huynh 2015: i.m. alfaxalone alone in 10 rabbits gave dose-dependent immobilisation (36.9 min at 4 mg/kg to 58.4 min at 8 mg/kg) with ear-pinch and limb-withdrawal reflexes preserved at every dose

Three-way, complete block, cross-over trial (record's own wording); publication type: Clinical Trial

Who: Rabbits (Companion Exotics / laboratory): 10 healthy New Zealand white rabbits used to evaluate a single intramuscular injection of alfaxalone at three doses (4, 6 and 8 mg/kg), in a three-way, complete block, cross-over trial, aiming to determine an intramuscular alfaxalone dose for safe immobilisation. Mean duration of effect, time to loss of the righting reflex, and responses to ear pinching and limb withdrawal were recorded.

Result: The mean duration of the effect for the 4, 6 and 8 mg/kg doses was, respectively, 36.9 (95% CI (31.6 to 42.3)), 51.8 (46.4 to 57.2) and 58.4 (52.8 to 63.9) minutes. Loss of the righting reflex was achieved after 3.1 (2.5 to 3.8), 2.4 (1.7 to 3.1) and 2.3 (1.6 to 2.9) minutes, respectively. The mean duration for the 6 and 8 mg doses was significantly higher than for the 4 mg dose (estimated differences of 14.8, 95% CI (8.8 to 20.8) minutes and 21.4 (15.3 to 27.6) minutes, respectively). No significant dose effect was observed before the loss of the righting reflex (P = 0.14). Ear pinching and limb withdrawal were elicited in all groups at every dose. The authors concluded that doses of 4 or 6 mg/kg could be recommended, and that higher doses do not provide clinical benefits and can be associated with anaesthetic complication.

Watch out: Intramuscular alfaxalone alone is immobilisation/sedation, not surgical anaesthesia — nociceptive reflexes were preserved at every dose — and there is no comparator drug in this study. It anchors what alfaxalone alone does in rabbits; combination protocols (Knutson, Navarrete-Calvo) behave differently.

Huynh M, Poumeyrol S, Pignon C, Le Teuff G, Zilberstein L. Intramuscular administration of alfaxalone for sedation in rabbits. The Veterinary record. 2015;176(10):255. PMID: 25433053. Registry ID: none in the record. MeSH: Anesthesia/methods/*veterinary · Anesthetics/*administration & dosage · Animals · Cross-Over Studies · Dose-Response Relationship, Drug · Injections, Intramuscular/veterinary · Male · Pregnanediones/*administration & dosage · *Rabbits

Synthesis: alfaxalone and ketamine protocols sedate rabbits equally in the one direct comparison; the depression warning belongs to medetomidine-premedicated alfaxalone induction, and ketamine–medetomidine itself depresses heart rate and SpO2

Synthesis

Who: Synthesis of the cards above: Knutson 2022 (9 healthy New Zealand White rabbits, randomised complete crossover, blinded scorer, alfaxalone–butorphanol–midazolam vs ketamine–butorphanol–midazolam sedation), Grint 2008 (50 client-owned rabbits of different breeds, randomised prospective blinded clinical trial, ketamine–medetomidine vs ketamine–midazolam for neutering), Navarrete-Calvo 2014 (10 New Zealand White rabbits, crossover, medetomidine–morphine premedication + alfaxalone induction) and Huynh 2015 (10 healthy New Zealand White rabbits, three-way crossover, i.m. alfaxalone dose comparison).

Result: (1) Direct comparison: median total sedation score 10 (8 to 10) on alfaxalone–butorphanol–midazolam vs 10 (6 to 10) on ketamine–butorphanol–midazolam, physiologic parameters not significantly different, recumbency significantly longer with alfaxalone (Knutson). (2) Ketamine–medetomidine profile: loss of righting reflex 1.64 +/- 0.55 vs 2.28 +/- 0.66 minutes against ketamine–midazolam, with significantly lower HR, SpO2 and isoflurane settings and laryngospasm in 3 of the KMT rabbits (Grint). (3) Alfaxalone depression signal: postinduction apnoea 20 +/- 10 minutes (morphine 1 mg/kg) and 27 +/- 18 minutes (morphine 2 mg/kg) after medetomidine premedication and i.v. alfaxalone, with variables depressed throughout anaesthesia (Navarrete-Calvo). (4) Alfaxalone alone i.m.: duration 36.9-58.4 minutes across 4-8 mg/kg, reflexes preserved at all doses (Huynh).

Watch out: No carded record directly compares an alfaxalone protocol with ketamine–medetomidine for surgical anaesthesia in rabbits: the drafted Grint alfaxalone record (PMID: 18820329) has no abstract in PubMed and could not be carded, so the shelf's head-to-head rests on a 9-rabbit sedation crossover using a ketamine–butorphanol–midazolam comparator. Induction quality, depression and recovery claims should be read protocol-by-protocol, not as a class verdict.

Synthesis of Knutson KA et al. PMID: 36028310; Grint NJ et al. PMID: 18179655; Navarrete-Calvo R et al. PMID: 24408312; Huynh M et al. PMID: 25433053. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.